Amplification of Chromosomal Region 20ql3 in Invasive Breast Cancer: Prognostic Implications

Clinical Cancer Research

Volumn 1, Issue 12, 1995, Pages 1455-1461

  Tanner, Minna M ^a   Tirkkonen, Mika ^a   Kallioniemi, Anne ^a   Holli, Kaija ^a   Collins, Colin ^b   Kowbel, Dave ^b   Gray, Joe W ^c   Kallioniemi, O P ^a   Isola, Jorma ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CHROMOSOME 20Q; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 20; DISEASE-FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS;

EID: 0029563611     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Alitalo, K., and Schwab, M. Oncogene amplification in tumor cells. Adv. Cancer Res., 47: 235–281, 1986.
2. Schwab, M., and Amler, L. C. Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chromosomes & Cancer, 1: 181–193, 1990.
3. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177–182, 1987.
4. Borg, A., Baldetorp, B., Femo, M., Killander, D., Olsson, H., and Sigurdsson, H. ERBB2 amplification in breast cancer with a high rate proliferation. Oncogene, 6: 137–143, 1991.
5. Van de Vijver, M. J. Molecular genetic changes in human breast cancer. Adv. Cancer Res., 61: 25–56, 1993.
6. Kallioniemi, A., Kallioniemi, O-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818–821, 1992.
7. Kallioniemi, A., Kallioniemi, O-P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H. S., Pinkel, D., Gray, J. W., and Waldman, F. M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA, 91: 2156–2160, 1994.
8. Muleris, M., Almeida, A., Gerbault-Seureau, M., Malfoy, B., and Dutrillaux, B. Detection of DNA amplification in 17 primary breast carcinomas with homogenously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes & Cancer, 10: 160–170, 1994.
9. Guan, X-Y., Meltzer, P. S., Dalton, W. S., and Trent, J. M. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat. Genet., 8: 155–161, 1994.
10. Devilee, P., van Vliet, M., van Sloun, P., Dijkshoom, N. K., Hermans, J., Pearson, P. L., and Comelisse, C. J. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene, 6: 1705–1711, 1991.
11. Tanner, M., Tirkkonen, M., Kallioniemi, A., Collins, C., Stokke, T., Karhu, R., Kowbel, D., Shadravan, F., Hintz, M., Kuo, W. L., Waldman, F. M., Isola, J. J., Gray, J. W., and Kallioniemi, O-P. Increased copy number at 20ql3 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res., 54: 4257–4260, 1994.
12. Hartmann, W. H., Ozzello, L., and Sobin, L. H. (eds.), Histological typing of breast tumors, Ed. 2. Geneva, Switzerland: WHO, 1981.
13. Bloom, H. J. G., and Richardson, W. W. Histologic grading and prognosis in breast cancer. Br. J. Cancer, 11: 359–377, 1957.
14. Hyytinen, E., Visakorpi, T., Kallioniemi, A., Kallioniemi, O-P., and Isola, J. J. Improved technique for analysis of formalin-fixed, paraffin- embedded tumors by fluorescence in situ hybridization. Cytometry, 16: 93–99, 1994.
15. Stokke, T., Collins, C., Kuo, W-L., Kowbel, D., Shadravan, F., Tanner, M., Kallioniemi, A., Kallioniemi, O-P., Pinkel, D., Deaven, L., and Gray, J. W. A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis. Genomics, 26: 134–137, 1995.
16. Kallioniemi, O-P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., and Gray, J. W. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA, 89: 5321–5325, 1992.
17. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
18. Kallioniemi, O-P., Kallioniemi, A., Piper, J., Isola, J., Waldman, F. M., Gray, J. W., and Pinkel, D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes & Cancer, 53: 5929–5933, 1993.
19. Kallioniemi, O-P. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry, 9; 164–169, 1988.
20. Helin, H., Kallioniemi, O-P., and Isola, J. J. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Cancer (Phila.). 63: 1761–1767, 1989.
21. Dixon, W. J. BMDP Statistical Software. Berkeley: University of California Press, 1981.
22. Isola, J. J., Kallioniemi, O-P., Chu, L. W., Fuqua, S. A. W., Hilsenbeck, S. G., Osborne, C. K., and Waldman, F. M. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am. J. Pathol., 147: 905–911, 1995.
23. Stark, G. R. Regulation and mechanisms of mammalian gene amplification. Adv. Cancer Res., 61: 87–113, 1993.